Publications by authors named "Hussein E Gaballa"
Breast cancer is a heterogeneous disease that encompasses several distinct entities with different biological characteristics and clinical behavior. Basal subtype is considered as a prognostically unfavorable subset. The purpose of this study is to compare the clinico-pathological characteristics and outcome of basal vs.
View Article and Find Full Text PDFArticle Synopsis
- Doxorubicin and Gemcitabine show potential as effective treatments for advanced breast cancer, with this study assessing their combined efficacy and safety as a first-line therapy.
- The study involved 35 patients, primarily around 47 years old, with various treatment backgrounds and metastatic disease characteristics, and it found positive response rates, including a 57.1% overall response rate.
- Key outcomes included a median survival time of 16 months, with 74.2% of patients surviving at one year, and the study monitored for toxicity, leading to dose adjustments during treatment cycles.